Table of Contents
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Market Forecasting
- Executive Summary
- Market Overview
-
- Market Dynamics
- Drivers
- Restraints
- Key Market Trends
- Industry Speaks
- Market Dynamics
- Key Revenue Pockets
- Global Life Sciences Software Market - Size & Forecast (2021-2028), By Value Chain
- Drug Discovery
- Drug Development/ CTMS
- Drug Manufacturing
- Commercialization, RWE & Pharmacovigilance
- Global Life Sciences Software Market - Size & Forecast (2021-2028), By Delivery Model
- On-Premise
- On-demand/Cloud
- Global Life Sciences Software Market - Size & Forecast (2021-2028), By End User Type
- Pharmaceutical Companies
- Biotechnology Companies
- Other End Users
- Global Life Sciences Software Market - Size & Forecast (2021-2028), By Region
- North America (U.S. & Canada)
- Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
- Asia Pacific (China, India, Japan, Rest of Asia Pacific)
- Rest of the World (Latin America, Middle East & Africa)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Competitive Positioning of Key Players (2022)
- Offerings Assessment, By Player
- Key Strategies Assessment, By Player (2021-2023)
- New Product & Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Key Companies Scanned (Indicative List)
- Dassault Systmes
- LabVantage
- PerkinElmer
- Schrodinger
- ICON
- Veeva
- PhlexGlobal
- Saama Technologies
- IQVIA
- Parexel
- Calyx
- Salesforce
- ConcertAI
- Abbott
- Science37
- Healx
- Medidata
- IBM Watson Health
- Koneksa
- SAP
- Oracle
- Optibrium
- Verily
- Exploristics
- Other Prominent Players